ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · IEX Real-Time Price · USD
6.18
-0.09 (-1.44%)
At close: Jul 2, 2024, 4:00 PM
6.13
-0.05 (-0.81%)
After-hours: Jul 2, 2024, 7:59 PM EDT
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $4.27 billion as of July 2, 2024. Its market cap has increased by 264.42% in one year.
Market Cap
4.27B
Enterprise Value
5.00B
1-Year Change
264.42%
Ranking
Category
Stock Price
$6.18
Market Cap Chart
Since July 28, 2015, ImmunityBio's market cap has increased from $2.67B to $4.27B, an increase of 60.31%. That is a compound annual growth rate of 5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 4.34B | 29.36% |
| Dec 29, 2023 | 3.35B | 65.16% |
| Dec 30, 2022 | 2.03B | -16.05% |
| Dec 31, 2021 | 2.42B | 67.01% |
| Dec 31, 2020 | 1.45B | 288.28% |
| Dec 31, 2019 | 372.80M | 305.66% |
| Dec 31, 2018 | 91.90M | -74.24% |
| Dec 29, 2017 | 356.80M | -24.28% |
| Dec 30, 2016 | 471.20M | -66.52% |
| Dec 31, 2015 | 1.41B | -47.21% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Option Care Health | 4.78B |
| BridgeBio Pharma | 4.70B |
| CRISPR Therapeutics AG | 4.60B |
| Apellis Pharmaceuticals | 4.54B |
| Select Medical Holdings | 4.54B |
| PACS Group | 4.44B |
| RadNet | 4.29B |
| Haemonetics | 4.19B |